Rhodopsin is mislocalized in the photoreceptor cell bodies in the
tulp1−/− mutant. A loss of polarity in rhodopsin
distribution is not sufficient evidence for a primary defect in the
pathway that targets nascent rhodopsin to the outer segments. It has
been found in the
rds mutant mice, which do not support any
outer segment formation,
22 and in the late stage of
degeneration in the
rd and RCS models when the outer
segments have disappeared.
23 24 Thus, mislocalization of
rhodopsin can be a secondary response to the blocked outer segment
formation. Our previous study
7 examined the
tulp1−/− retinas at a relatively early age (17–21
postnatal days) when the photoreceptor outer segments are still
preserved. This would suggest that rhodopsin mislocalization in this
mutant occurs at the early stage of disease and represents a primary
defect. To strengthen this argument, we expanded our studies in the
current work to mutant retinas at postnatal day 12 and found that
rhodopsin is also mislocalized. Because the
rd mouse has a
much faster course of disease than the
tulp1−/− mouse and
yet at the same age is able to maintain a better partitioning of
rhodopsin in the outer segments, we conclude that rhodopsin
mislocalization in the
tulp1 mutant retinas is indeed an
early and primary defect. Rhodopsin distribution in other rodent models
of retinal degeneration also supports the notion that rhodopsin
mislocalization in the
tulp1 mutant is a direct consequence
of missing TULP1 function. For example, predominant rhodopsin
localization in the outer segments has been found in the rhodopsin P23H
transgenic mice and rats
25 26 27 and in the T17M transgenic
mice.
7 A line of P23H rhodopsin transgenic mice (L line)
has a much faster rate of degeneration than the
tulp1 mutant. Yet when examined at postnatal day
15, rhodopsin was found predominantly in the outer
segments.
25